The Link Between Adrenal Insufficiency and High Potassium

Adrenal insufficiency raises potassium levels because the adrenal glands fail to produce enough aldosterone, the hormone that signals your kidneys to flush potassium out of your body. Without adequate aldosterone, potassium accumulates in the blood, a condition called hyperkalemia. The connection is tight enough that an unexpectedly high potassium reading on routine blood work sometimes turns out to be the first clue that someone has adrenal insufficiency. But the severity, the speed at which potassium climbs, and even whether it climbs at all depend on which type of adrenal insufficiency is involved and what else is happening in the body.

How Aldosterone Keeps Potassium in Check

Aldosterone is a hormone made in the outer layer of the adrenal glands. Its main job in the kidneys is straightforward: it tells specific cells in the distal part of the nephron to reabsorb sodium back into the bloodstream and, in exchange, excrete potassium into the urine. When aldosterone levels are normal, this exchange keeps blood potassium within a narrow range, roughly 3.5 to 5.0 mmol/L. Aldosterone also influences potassium and sodium handling beyond the kidneys, including in sweat glands, salivary glands, and the lining of the colon.1Europe PMC. Extrarenal Effects of Aldosterone on Potassium Homeostasis But the kidney is where the heavy lifting happens, and it is the kidney pathway that matters most when aldosterone drops.

The system that controls aldosterone release is the renin-angiotensin-aldosterone system, or RAAS. When blood pressure falls or sodium dips, the kidneys release renin, which triggers a cascade ending in aldosterone production. A rise in blood potassium itself also directly stimulates aldosterone release. So the system is self-correcting under normal circumstances: potassium creeps up, aldosterone rises in response, the kidneys dump more potassium, and levels come back down. Adrenal insufficiency breaks that feedback loop.

Why Primary Adrenal Insufficiency Hits Potassium Hardest

The distinction between primary and secondary adrenal insufficiency is important here because the two types affect potassium differently. In primary adrenal insufficiency, often called Addison’s disease, the adrenal glands themselves are damaged, usually by autoimmune attack, infection, or hemorrhage. Because the glands are destroyed, production of both cortisol and aldosterone drops. The loss of aldosterone is what drives potassium up. Without it, the kidneys hold onto potassium instead of excreting it, and blood levels climb.

In secondary adrenal insufficiency, the problem sits higher up, in the pituitary gland or hypothalamus, which fail to send adequate signals (via ACTH) to the adrenals. Here, cortisol production falls, but aldosterone secretion is largely preserved because aldosterone is regulated more by potassium and the renin-angiotensin system than by ACTH. So people with secondary adrenal insufficiency usually do not develop high potassium as a hallmark feature. When someone presents with low sodium and high potassium together, it points more strongly toward a primary adrenal problem.

There is a third scenario worth knowing. Chronic use of exogenous steroids (like prednisone) can suppress ACTH for so long that the adrenal glands atrophy globally, including the aldosterone-producing zona glomerulosa. If that person is then given a medication that further suppresses aldosterone, such as an ACE inhibitor, the combination can push potassium dangerously high. One case report described exactly this: a patient with chronic adrenal insufficiency from steroid use developed persistent hyperkalemia after starting lisinopril, because both the disease and the drug were suppressing aldosterone simultaneously.2Europe PMC. Type IV RTA in Chronic Adrenal Insufficiency and Concomitant Lisinopril Treatment

What High Potassium Actually Does to the Body

Mild hyperkalemia often produces no symptoms at all, which is part of what makes it dangerous. As levels rise above roughly 6.0 mmol/L, the effects become more noticeable and more serious. Potassium is critical for the electrical signaling that drives muscle contraction, including in the heart. When blood levels are too high, that signaling goes haywire.

The heart is the organ at greatest immediate risk. On an ECG, early signs of hyperkalemia include peaked, tent-shaped T waves. As potassium climbs further, the QRS complex widens, meaning the electrical impulse is taking longer to spread through the heart muscle. At very high levels, the heart can slip into dangerous rhythms or stop altogether. In one reported case, a 39-year-old man showed up to the emergency department unable to move his legs. His ECG showed the classic hyperkalemia pattern of widened QRS complexes and peaked T waves, and his leg paralysis turned out to be the first sign of undiagnosed Addison’s disease.3Europe PMC / PubMed Central. Hyperkalemia-induced Leg Paresis in Primary Adrenal Insufficiency

Muscle weakness and paralysis happen because potassium affects skeletal muscles too. When the concentration outside muscle cells is too high, the electrical gradient that allows normal contraction becomes disrupted. The legs are typically affected first, which can mimic a neurological emergency. Tingling, numbness, and generalized fatigue are also common complaints. Gastrointestinal symptoms like nausea and cramping sometimes appear as well, though they are less specific.

Adrenal Crisis and the Potassium Emergency

An adrenal crisis is the most dangerous acute scenario. It typically happens when someone with adrenal insufficiency faces a physiological stress, like an infection, surgery, or trauma, without adequate cortisol coverage. The body’s demand for cortisol spikes, supply is absent, and things unravel quickly: blood pressure plummets, blood sugar drops, sodium falls, and potassium surges. Clinical guidelines for managing adrenal crisis specifically call for evaluating and correcting hyperkalemia alongside fluid deficit, low blood sugar, and low sodium.4Europe PMC / Journal of Clinical Research in Pediatric Endocrinology. Treatment and Prevention of Adrenal Crisis and Family Education

In the emergency setting, treating the hyperkalemia itself follows a familiar playbook regardless of the underlying cause. Intravenous calcium stabilizes the heart’s electrical activity within minutes but does not lower potassium levels. Insulin combined with glucose drives potassium from the blood back into cells temporarily. Sodium bicarbonate may help if there is accompanying acidosis. The case of the man with leg paralysis illustrates this: his ECG abnormalities and weakness resolved rapidly after receiving calcium chloride, insulin, and glucose, even before the underlying Addison’s disease was formally diagnosed.3Europe PMC / PubMed Central. Hyperkalemia-induced Leg Paresis in Primary Adrenal Insufficiency The crucial step is recognizing that the potassium problem is a symptom of the adrenal problem, so that hormone replacement begins alongside the emergency potassium-lowering measures.

Long-Term Management With Fludrocortisone

Once primary adrenal insufficiency is diagnosed, controlling potassium over the long term depends heavily on mineralocorticoid replacement, most commonly fludrocortisone. This synthetic drug mimics aldosterone’s action in the kidneys, restoring the sodium-potassium exchange that the body can no longer manage on its own. Standard dosing ranges from 0.05 to 0.2 mg daily, taken as a single oral dose.5PubMed. Mineralocorticoid substitution and monitoring in primary adrenal insufficiency

Getting the dose right matters, and it is not always straightforward. Too little fludrocortisone leaves potassium elevated and sodium low. Too much can cause high blood pressure, ankle swelling, and dangerously low potassium. In a long-term follow-up study, most patients required around 0.2 mg per day to maintain potassium near 3.6 mmol/L and sodium around 140.5 mmol/L.6The Journal of Clinical Endocrinology & Metabolism. Primary Adrenal Insufficiency: Managing Mineralocorticoid Replacement Therapy A separate six-year study confirmed that the effect of fludrocortisone on potassium is dose-dependent: higher doses correlated with lower potassium levels, while lower doses were associated with higher potassium and higher renin.7PubMed Central. Renin and electrolytes indicate the mineralocorticoid activity of fludrocortisone: a 6 year study in primary adrenal insufficiency

Monitoring typically involves regular blood tests for sodium, potassium, and plasma renin activity. The clinical goal is generally to keep renin in the upper normal range, which suggests the kidneys are getting just enough mineralocorticoid signal without being overwhelmed. What makes monitoring tricky is that a study of patients taken off fludrocortisone showed that hyperkalemia developed in every patient after withdrawal, regardless of what renin and angiotensin levels were doing. In other words, potassium can climb even when other lab markers look reassuring.8Oxford Academic (Acta Endocrinologica / European Journal of Endocrinology). Effects of fludrocortisone withdrawal on plasma angiotensin II, ACTH, vasopressin, and potassium in patients with Addison’s disease This finding reinforces that potassium itself should be measured directly rather than inferred from other tests.

When Medications Mimic or Worsen the Problem

A substantial portion of hyperkalemia cases in the general population are not caused by adrenal disease at all but by medications that interfere with aldosterone signaling. ACE inhibitors, angiotensin receptor blockers (ARBs), and direct renin inhibitors all reduce aldosterone levels by blocking the RAAS cascade. Potassium-sparing diuretics like spironolactone block the aldosterone receptor itself. NSAIDs, beta blockers, heparin, calcineurin inhibitors (used in transplant patients), and even the antibiotic trimethoprim can all nudge potassium upward.9Europe PMC. An Overview of Clinically Imperative and Pharmacodynamically Significant Drug Interactions of Renin-Angiotensin-Aldosterone System (RAAS) Blockers

The risk multiplies when these drugs are combined. Adding spironolactone to an ACE inhibitor in someone with reduced kidney function or diabetes can produce severe hyperkalemia.9Europe PMC. An Overview of Clinically Imperative and Pharmacodynamically Significant Drug Interactions of Renin-Angiotensin-Aldosterone System (RAAS) Blockers For someone who already has adrenal insufficiency, even a single one of these drugs can tip the balance. The case of the patient with chronic adrenal insufficiency who developed persistent hyperkalemia on lisinopril is a clear illustration: the drug reduced the already-limited aldosterone further, creating a potassium problem that persisted even after the obvious causes were addressed.2Europe PMC. Type IV RTA in Chronic Adrenal Insufficiency and Concomitant Lisinopril Treatment

This overlap is clinically important because heart failure, high blood pressure, and kidney disease are all common conditions treated with RAAS-blocking drugs, and these are also the patients most vulnerable to hyperkalemia. If someone on these medications develops unexplained hyperkalemia that does not respond normally to dose adjustments, unrecognized adrenal insufficiency should be on the list of possibilities.

The Rare Exception That Proves the Rule

The association between adrenal insufficiency and high potassium is strong enough that when the opposite occurs, it gets published as a case report. One such report described a patient diagnosed with Addison’s disease whose potassium was 2.3 mmol/L, well below the normal lower limit of 3.5. This was “unusual” enough to warrant investigation. The authors noted that primary adrenal insufficiency is typically associated with hyperkalemia or at least normal potassium, and that finding severely low potassium alongside it is a genuine oddity.10Europe PMC. Addison’s disease associated with hypokalemia: a case report

What could cause such a contradiction? In that case, the patient had other factors pulling potassium down: vomiting, diarrhea, and poor intake had depleted potassium stores faster than the aldosterone deficiency could accumulate them. The lesson is that while aldosterone deficiency pushes potassium up, other forces can push it down at the same time. The net effect depends on which force wins. In most people with untreated Addison’s disease, aldosterone deficiency dominates, and potassium rises. But clinicians cannot assume high potassium will always be present, especially if the patient is dehydrated or losing electrolytes through the gut.

Newborns and Congenital Adrenal Hyperplasia

One population where the adrenal-potassium link shows up with particular urgency is newborns with the salt-wasting form of congenital adrenal hyperplasia (CAH). In this inherited condition, an enzyme needed to make both cortisol and aldosterone is deficient from birth. The adrenal glands cannot produce enough of either hormone, leading to a salt-losing crisis typically within the first week or two of life. Sodium plummets, potassium spikes, and the infant can develop life-threatening dehydration and cardiovascular collapse if not treated quickly.11PubMed Central. A Neonate Presenting with Severe Dehydration: A Rare Case of Congenital Adrenal Hyperplasia with Salt Losing Crisis

Many countries now include CAH in their newborn screening panels precisely because catching it before a crisis can be lifesaving. A heel-prick blood test measures 17-hydroxyprogesterone, a precursor that accumulates when the enzyme is blocked. If levels are elevated, confirmatory testing and treatment with hydrocortisone and fludrocortisone can begin within days, preventing the dangerous electrolyte swings. For parents of affected infants, understanding that their child’s body cannot properly clear potassium or retain sodium is critical for recognizing early warning signs of crisis, especially during common childhood illnesses that increase stress on the body.

How Doctors Distinguish Aldosterone Deficiency From Other Causes

When hyperkalemia shows up on lab work, the first question is whether the kidneys are failing to excrete potassium or whether it is being released from cells in abnormal amounts (as in tissue injury or severe acidosis). Urine testing can help sort this out. If the kidneys are functioning normally and aldosterone is adequate, they should be aggressively dumping potassium in response to elevated blood levels. Measurements like the ratio of urinary sodium to urinary potassium and the fractional excretion of potassium can indicate whether the kidney’s potassium-handling machinery is being appropriately stimulated by aldosterone.12ScienceDirect. Beyond the transtubular potassium gradient: Alternative urinary markers for diagnosing hypoaldosteronism

If the urine tests suggest the kidneys are not clearing potassium as expected, measuring serum aldosterone and renin helps pinpoint why. In primary adrenal insufficiency, aldosterone is low and renin is high, because the kidneys keep signaling for more aldosterone that the adrenals cannot make. In drug-induced suppression, aldosterone is low but renin may also be low (since the drugs block the entire RAAS cascade). In type IV renal tubular acidosis, which can accompany both adrenal disease and diabetes, the kidneys themselves are resistant to aldosterone’s signal. Each pattern requires a different management approach, and potassium is often the lab value that gets the diagnostic ball rolling.

Aldosterone’s Deep Evolutionary Roots

The tight connection between aldosterone and potassium is not an accident of human physiology. It reflects hundreds of millions of years of evolution. When vertebrate ancestors transitioned from aquatic to terrestrial environments, conserving salt and water became a survival priority. The RAAS evolved as a system to manage this challenge, allowing land-dwelling animals to hold onto sodium (which is scarce in many terrestrial diets) while excreting potassium (which is abundant in plant-based foods).13PubMed. Epithelial sodium transport and its control by aldosterone: the story of our internal environment revisited The sodium-potassium pump, which sits in virtually every cell membrane, predates the aldosterone system itself and was co-opted by RAAS to fine-tune extracellular fluid composition.

This evolutionary context helps explain why the system is so tightly regulated and why its failure produces such rapid consequences. Potassium is the most abundant cation inside cells, and even small shifts in the ratio between intracellular and extracellular potassium alter the electrical properties of every excitable tissue in the body. The aldosterone system acts as a pressure valve: it ensures that dietary potassium intake, which can vary enormously day to day, does not translate into dangerous swings in blood potassium. When adrenal disease removes that valve, the system loses its primary safety mechanism, and potassium drifts upward with each meal.

Meera Trivedi

Meera Trivedi is a reproductive endocrinologist with 17 years of experience in fertility care. She earned her MD at Johns Hopkins University and is board certified by the American Board of Obstetrics and Gynecology in obstetrics and gynecology and in reproductive endocrinology and infertility. At a university fertility center she manages IVF, ovulation induction and PCOS. Her articles explain fertility treatment, the hormones that drive ovulation, and what happens in early IVF pregnancies.